Novo Nordisk hits back at copycat drugs

10 de febrero de 2026 · 11m

FT News Briefing

Play — keeps going as you browse

Aún sin valorar

Comentarios

los más antiguos primero

Inicia sesión para unirte a la conversación.

Notas del programa

Gilts rebounded from earlier losses on Monday afternoon, and Novo Nordisk is suing US telehealth company Hims & Hers over ‘knock-off’ versions of its weight-loss drugs. Plus, France’s central bank chief is stepping down early, and US senators are pushing proposals to lift bank deposit insurance limits to avoid another Silicon Valley Bank debacle.

Mentioned in this podcast:

Gilts stabilise after cabinet voices support for Keir Starmer

Novo Nordisk sues Hims & Hers over copycat weight-loss drugs

Novo Nordisk faces more gloom from price cuts in crowded anti-obesity drugs market

French central bank governor to step down early

Can the US crack the formula for ending bank runs?

Note: The FT does not use generative AI to voice its podcasts

Today’s FT News Briefing was hosted and produced by Sonja Hutson. Our show was mixed by Kelly Garry. Additional help from Gavin Kallmann, Michael Lello and David da Silva. Our executive producer is Topher Forhecz. Cheryl Brumley is the FT’s Global Head of Audio. The show’s theme music is by Metaphor Music.

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

Más episodios

Fed holds rates as inflation fears grow30 jul The Big Tech earnings dilemma29 jul Ares’ big play in private equity28 jul Hike or hold: Investors split ahead of Fed decision27 jul Oil hits $100 and drives global bond sell-off24 jul

Dónde escuchar

Dónde escuchar FT News Briefing

Escuchar en Apple Podcasts